We are live on ! Find out more
ACHV icon

Achieve Life Sciences
ACHV

32 hedge funds and large institutions have $15.2M invested in Achieve Life Sciences in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 4

22% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 9

10% more funds holding

Funds holding: 29 → 32 (+3)

2.74% less ownership

Funds ownership: 21.6% → 18.87% (-2.7%)

12% less capital invested

Capital invested by funds: $17.3M → $15.2M (-$2.11M)

Holders
32
Holders Change
+3
Holders Change %
+10.34%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
11
Reduced
9
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
GCP
GSA Capital Partners
United Kingdom
+$302K
2
Franklin Resources
Franklin Resources
California
+$267K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$227K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$199K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$157K

Top Sellers

1
Millennium Management
Millennium Management
New York
-$916K
2
Renaissance Technologies
Renaissance Technologies
New York
-$426K
3
Morgan Stanley
Morgan Stanley
New York
-$222K
4
Two Sigma Investments
Two Sigma Investments
New York
-$203K
5
SC
Shay Capital
New York
-$179K
Name Holding Trade Value Shares
Change 		Change in
Stake
SC
1
Shay Capital
New York
$3.23M -$179K -22,785 -6%
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.29M +$157K +19,975 +8%
PCM
3
Perkins Capital Management
Minnesota
$1.44M -$19.6K -2,500 -1%
6CM
4
683 Capital Management
New York
$1.06M – – –
ACM
5
Altium Capital Management
New York
$1.04M – – –
CC
6
Clearline Capital
New York
$1.04M +$1.57K +200 +0.2%
Morgan Stanley
7
Morgan Stanley
New York
$942K -$222K -28,331 -20%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$727K +$227K +28,885 +51%
LPL Financial
9
LPL Financial
California
$612K +$25.1K +3,200 +5%
GCP
10
GSA Capital Partners
United Kingdom
$327K +$302K +38,491 New
Franklin Resources
11
Franklin Resources
California
$289K +$267K +34,050 New
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
$271K +$9.41K +1,200 +4%
Two Sigma Advisers
13
Two Sigma Advisers
New York
$245K -$113K -14,400 -33%
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
$215K +$199K +25,337 New
OC
15
Oppenheimer & Co
New York
$213K +$15.7K +2,000 +9%
Renaissance Technologies
16
Renaissance Technologies
New York
$192K -$426K -54,360 -71%
Two Sigma Investments
17
Two Sigma Investments
New York
$158K -$203K -25,887 -58%
Northern Trust
18
Northern Trust
Illinois
$147K +$1.7K +216 +1%
State Street
19
State Street
Massachusetts
$125K – – –
ASN
20
Advisory Services Network
Georgia
$111K +$102K +13,000 New
OQS
21
Occudo Quantitative Strategies
Florida
$110K -$48K -6,114 -32%
TPA
22
Trivium Point Advisory
Connecticut
$98K +$3.53K +450 +4%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$93K -$130K -16,531 -60%
VF
24
Virtu Financial
New York
$85K +$78.8K +10,039 New
Wells Fargo
25
Wells Fargo
California
$39K +$29K +3,697 +414%
1
2

ACHV Hedge Fund Activity: Q3 2021 in Review

32 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q3 2021, worth a combined $15.2M — down 12% from $17.3M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new ACHV positions and 4 closed out — a net gain of 4 holders — while 11 added to existing stakes and 9 trimmed.

The largest buyer was GSA Capital Partners, opening a new position worth an estimated $302K. The largest seller was Millennium Management, exiting entirely with an estimated $916K sold.

  • 32 institutional investors held Achieve Life Sciences (ACHV) as of Q3 2021, up from 29 in Q2 2021.
  • Funds reported $15.2M of Achieve Life Sciences stock for Q3 2021, down 12% quarter-over-quarter.
  • 8 funds opened new Achieve Life Sciences positions in Q3 2021 and 4 closed out, a net change of +4 holders.
  • The largest Achieve Life Sciences buyer in Q3 2021 was GSA Capital Partners, an estimated $302K added.
  • The largest Achieve Life Sciences seller in Q3 2021 was Millennium Management, an estimated $916K sold.

Based on aggregated 13F filings for Q3 2021.